慢性阻塞性肺部疾病的异性表型:临床特征,生物标志物和生物疗法
Mauro Maniscalco1, Claudio Candia1, Pasquale Ambrosino2
1Istituti Clinici Scientifici Maugeri IRCCS, Pulmonary Rehabilitation Unit of Telese Terme Institute, Italy; Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy.
European journal of internal medicine
|October 23, 2024
概括
异性慢性阻塞性肺病 (COPD) 现型通过异性蛋白升高来识别,指导针对性治疗,如皮质类固醇和生物药物. 研究正在推进,以定义这些表型,并探索新的治疗方法.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种异质的炎症性气道疾病,具有持续的空气流限制.
- 尽管接受治疗,但由于疾病异质性和各种表型,一些COPD患者仍然表现出症状.
- 乙酸性炎症是一种显著的COPD表型,对于识别受益于特定疗法的患者至关重要.
研究的目的:
- 总结和讨论关于eosinophilic COPD的关键文献发现.
- 确定这种特定的COPD表型的生物和临床特征.
- 审查已建立和新兴的生物标志物和治疗策略,以色素性COPD.
主要方法:
- 文献综述和关键研究发现的综合.
- 对临床试验数据的分析和对eosinophilic COPD的自发研究.
- 讨论诊断标准,生物标志物和治疗进展.
主要成果:
- 乙性COPD表型对皮质类固醇和生物药物有良好的反应.
- 对于用于诊断的乙素细胞计数切断值,没有普遍的共识.
- 进展包括新生物标志物和杜皮卢马布在特定COPD患者的批准.
结论:
- 识别eosinophilic COPD表型对于个性化治疗策略至关重要.
- 需要进一步的研究来确定确切的诊断标准和优化治疗方法.
- 新兴的生物标志物和向生物药物为治疗异性慢性肺炎提供了有希望的未来前景.
相关概念视频
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20COPD: Pathogenesis and Clinical Features
238
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
238
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K